KEGG   DRUG: Sacituzumab govitecanHelp
Entry
D10985                      Drug                                   

Name
Sacituzumab govitecan (USAN/INN);
Sacituzumab govitecan-hziy;
Trodelvy (TN)
Product
Remark
Product: D10985<US>
Efficacy
Antineoplastic, Topoisomerase I inhibitor
  Disease
Breast cancer (triple negative) [DS:H00031]
Comment
Antibody-drug conjugate
Target
TOP1 [HSA:7150] [KO:K03163]
TACSTD2 (TROP2) [HSA:4070] [KO:K17288]
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   Other
    TACSTD2 (TROP2)
     D10985  Sacituzumab govitecan (USAN/INN) <US>
 Enzymes
  Isomerases (EC5)
   DNA topoisomerase
    TOP1
     D10985  Sacituzumab govitecan (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10985
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10985
BRITE hierarchy
Other DBs
CAS: 1491917-83-9
PubChem: 350078336
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system